Tuesday, July 1, 2025
23.7 C
London
HomeFinTechVero Biotech: Secures $50M in Funding

Vero Biotech: Secures $50M in Funding

Date:

Yonder Launches Innovative Debit Cards for Travel Enthusiasts

Discover How Yonder is Redefining Travel Payments with Cutting-Edge...

Launch of Pan-African Card Scheme: A New Step Towards Regional Financial Integration

Discover how the latest card scheme can revolutionize banking...

AI Agent’s Identity Crisis in Vending Machine Business

Exploring the Challenges and Innovations of AI in Automated...
  • Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m
  • Runway Growth Capital provided the financing
  • Vero Biotech (formerly known as GeNO LLC), a biotechnology company focused on the design, development, and commercialization of next-generation products
  • The company also developed the GENOSYL® Delivery System (GENOSYL DS), a inhaled nitric oxide delivery system approved by the U.S. Food and Drug Administration (FDA)
  • The GENOSYL DS transforms the delivery and use of nitric oxide, a vasodilator proven to play a critical role in the care of patients with adult respiratory distress syndrome
  • The GENOSYL® Delivery System authorized by the U.S. FDA for expanded emergency use access for patients with cardiopulmonary complications

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories